Envoy Medical, Inc.

Envoy Medical, Inc. (Nasdaq: ANZU) is a medical device company specializing in implantable hearing solutions, including its Esteem fully implanted active middle ear device and the Acclaim fully implanted cochlear implant system. The company reached public markets through a business combination with Anzu Special Acquisition Corp., a blank-check vehicle sponsored by Anzu Partners that completed its IPO in 2021 targeting the healthcare and medical technology sector. The de-SPAC merger closed in late 2022, after which Envoy Medical began trading on Nasdaq under the ANZU ticker. The company filed its 10-K annual report with the SEC on April 3, 2023, covering its first fiscal year as a publicly traded entity. Sign up on SpacDesk for full filings, sponsor profiles, and deal analytics on Envoy Medical and the broader SPAC universe.